Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations

Movement Disorders

Volumn 26, Issue 1, 2011, Pages 142-147

  Meppelink, Anne Marthe ^a,b   De Jong, Bauke M ^a,b   Teune, Laura K ^a,b   Van Laar, Teus ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

MRI; Parkinson's disease; VBM; Visual hallucinations

Indexed keywords

ARTICLE; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN METABOLISM; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMENTIA; GRAY MATTER LOSS; HUMAN; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL GYRUS; PARIETAL CORTEX; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; VISUAL HALLUCINATION; VOXEL BASED MORPHOMETRY;

ANALYSIS OF VARIANCE; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; HALLUCINATIONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; NEURONS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 79951470406     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23375     Document Type: Article

References (46)

1. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998; 339: 1044-1053.
2. Selby G. Cerebral atrophy in Parkinsonism. J Neurol Sci 1968; 6: 517-559.
3. Schneider E, Fischer PA, Jacobi P, Becker H, Hacker H. The significance of cerebral atrophy for the symptomatology of Parkinson's disease. J Neurol Sci 1979; 42: 187-197.
4. Dagher A, Nagano-Saito A. Functional and anatomical magnetic resonance imaging in Parkinson's disease. Mol Imaging Biol 2007; 9: 234-242.
5. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2007; 27: 597-605.
6. Meppelink AM, de Jong BM, Renken R, et al. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 2009; 132: 2980-2993.
7. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007; 14: 750-756.
8. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, et al. Differential progression of brain atrophy in Parkinson disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 2010; 81: 650-657.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
10. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003; 61: 1222-1228.
11. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-1626.
12. Friston KJ, Holmes AP, Poline JB, et al. Analysis of fMRI time-series revisited. Neuroimage 1995; 2: 45-53.
13. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995; 28: 240-258.
14. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125: 391-403.
15. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000; 123(Pt 4): 733-745.
16. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005; 4: 605-610.
17. Imamura K, Wada-Isoe K, Kitayama M, Nakashima K. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations. Acta Neurol Scand 2008; 117: 255-259.
18. Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Tolosa E. Cognitive changes in Parkinson's disease patients with visual hallucinations. Dement Geriatr Cogn Disord 2007; 23: 281-288.
19. Meppelink AM, Koerts J, Borg M, Leenders KL, van Laar T. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations. Mov Disord 2008; 23: 1906-1912.
20. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392.
21. Santangelo G, Trojano L, Vitale C, et al. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov Disord 2007; 22: 2418-2425.
22. Kempster PA, Williams DR, Selikhova M, et al. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007; 130: 2123-2128.
23. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791-800.
24. Pereira JB, Junque C, Marti MJ, et al. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009; 24: 1193-1199.
25. Summerfield C, Junque C, Tolosa E, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005; 62: 281-285.
26. Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-basedmorphometry. J Neurol Neurosurg Psychiatry 2007; 78: 254-259.
27. Tir M, Delmaire C, le Thuc V, et al. Motor-related circuit dysfunction in MSA-P: Usefulness of combined whole-brain imaging analysis. Mov Disord 2009; 24: 863-870.
28. Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005; 64: 224-229.
29. Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008; 23: 42-46.
30. Playford ED, Jenkins IH, Passingham RE, et al. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992; 32: 151-161.
31. Cunnington R, Egan GF, O'Sullivan JD, et al. Motor imagery in Parkinson's disease: a PET study. Mov Disord 2001; 16: 849-857.
32. de Jong BM, van Zomeren AH, Willemsen AT, Paans AM. Brain activity related to serial cognitive performance resembles circuitry of higher order motor control. Exp Brain Res 1996; 109: 136-140.
33. Huang C, Mattis P, Tang C, et al. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2007; 34: 714-723.
34. Jellinger KA. Formation and development of Lewy pathology: a critical update. J Neurol 2009; 256(suppl 3): 270-279.
35. Jellinger KA. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 2009; 1792: 730-740.
36. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134.
37. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64: 1404-1410.
38. Colosimo C, Hughes AJ, Kilford L, Lees AJ. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 852-856.
39. Parkkinen L, Pirttila T, Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 2008; 115: 399-407.
40. Draganski B, May A. Training-induced structural changes in the adult human brain. Behav Brain Res 2008; 192: 137-142.
41. Binkofski F, Buccino G, Stephan KM, et al. A parieto-premotor network for object manipulation: evidence from neuroimaging. Exp Brain Res 1999; 128: 210-213.
42. de Jong BM, van der Graaf FH, Paans AM. Brain activation related to the representations of external space and body scheme in visuomotor control. Neuroimage 2001; 14: 1128-1135.
43. de Jong BM, Willemsen AT, Paans AM. Brain activation related to the change between bimanual motor programs. Neuroimage 1999; 9: 290-297.
44. Wheaton LA, Hallett M. Ideomotor apraxia: a review. J Neurol Sci 2007; 260: 1-10.
45. Draganski B, Gaser C, Busch V, et al. Neuroplasticity: changes in grey matter induced by training. Nature 2004; 427: 311-312.
46. Jancke L, Koeneke S, Hoppe A, Rominger C, Hanggi J. The architecture of the golfer's brain. PLoS One 2009; 4: e4785.